About us
Founded in 2022, AllMyHealth is dedicated to transforming rare disease care by creating and distributing cutting-edge, tailored content to our trusted patient communities and partnerships.
Headquartered in Scale Space, at the heart of London’s innovation district, we're backed by global venture builder Blenheim Chalcot, which has built over 60 innovative technology businesses in the last 25 years.
Our vision
At AllMyHealth, we envision a world where every rare disease community has seamless access to the latest research and a strong support network. By empowering and connecting support organisations with a shared mission, we unlock greater potential to improve patient lives and drive meaningful progress.
By uniting trusted patient communities, leveraging cutting-edge generative AI, and forging strategic partnerships, we are transforming how rare disease patients navigate their healthcare journey. Our goal is to empower patients with the knowledge and tools they need to make informed decisions.
Our commitment
Trust, respect, and patient autonomy are fundamental to building a healthcare ecosystem that works for everyone. That's why you can count on us to always:
Hold ourselves to the highest data protection standards.
Maintain the utmost transparency.
Obtain informed consent.
Visit our Trust Centre to learn more.
Our team
With shared expertise across technology, academia, and health, we aim to serve individuals, communities, and organisations with empathy.
Join us in transforming rare disease support
Our growing ecosystem is already helping over 14,000 people worldwide.